February 2019
ProCore completes the first phase of its Multi center, Placebo Controlled Double Blind Clinical Study of RegenoGel
ProCore completes the first phase of its Multi center, Placebo Controlled Double Blind Clinical Study of RegenoGel and RegenoGel OSP, for Interim analysis of safety and efficacy.